Help | RSS Feed

Aurinia Pharmaceuticals (TSE:AUP) Seasonal Chart

Aurinia Pharmaceuticals (TSE:AUP) Seasonality

AUP.TO Relative to the S&P 500
AUP.TO Relative to the S&P 500

AUP.TO Relative to the Sector
AUP.TO Relative to the Sector

Monthly Seasonal Aurinia Pharmaceuticals (TSE:AUP)

Seasonal Chart Analysis

Analysis of the Aurinia Pharmaceuticals (TSE:AUP) seasonal charts above shows that a Buy Date of December 22 and a Sell Date of April 12 has resulted in a geometric average return of 18.17% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 41.64% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore